Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almut Schulze

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Cell Death and Differentiation|May 18, 2023
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancerCarina R Maier, Oliver Hartmann, Cristian Prieto-Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
Nature Metabolism|January 20, 2025
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulationMarteinn T Snaebjornsson, Philipp Poeller, Daria Komkova, et al.
Cell Death and Differentiation|April 25, 2025
An atlas of ferroptosis-induced secretomesF Isil Yapici, Eric Seidel, Alina Dahlhaus, et al.
Cell Death and Differentiation|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescenceMarkus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
Cell Reports|August 31, 2023
Formate promotes invasion and metastasis in reliance on lipid metabolismCatherine Delbrouck, Nicole Kiweler, Oleg Chen, et al.
Cancer & Metabolism|April 5, 2016
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environmentsBarrie Peck, Zachary T Schug, Qifeng Zhang, et al.
Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Nature Communications|February 27, 2026
Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failureManju Kumari, Ioannis Evangelakos, Anushka Deshpande, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Cell Death and Differentiation|May 18, 2023
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancerCarina R Maier, Oliver Hartmann, Cristian Prieto-Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
Nature Metabolism|January 20, 2025
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulationMarteinn T Snaebjornsson, Philipp Poeller, Daria Komkova, et al.
Cell Death and Differentiation|April 25, 2025
An atlas of ferroptosis-induced secretomesF Isil Yapici, Eric Seidel, Alina Dahlhaus, et al.
Cell Death and Differentiation|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescenceMarkus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
Cell Reports|August 31, 2023
Formate promotes invasion and metastasis in reliance on lipid metabolismCatherine Delbrouck, Nicole Kiweler, Oleg Chen, et al.
Cancer & Metabolism|April 5, 2016
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environmentsBarrie Peck, Zachary T Schug, Qifeng Zhang, et al.
Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Nature Communications|February 27, 2026
Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failureManju Kumari, Ioannis Evangelakos, Anushka Deshpande, et al.
Pageof 10